A new treatment process, often perceived to be radical by uninformed medical professionals, is breathing new life, hope, and often, unforeseen improvements into neuromuscular and neurodegenerative diseases of virtually every type. The new treatment process provides intervention for a condition that has been called Chronic Cerebro Spinal Vascular Insufficiency (CCSVI). However, research and clinical doctors are now considering a more accurate name, Chronic Cerebro Spinal Vascular Hypertension (CCSVH), since the latest realizations are that there is increased intracranial blood pressure occurring within one or more of the major veins in the head and neck.
There has been much controversy aroused by CCSVH within the neurology and cardiology communities. Neither camp seems to want to acknowledge that a vascular issue can cause such severe neurological problems.
Traditionally in modern medicine, for at least five decades, the treatment of neuromuscular and neurodegenerative diseases has been limited only to the management of symptoms. A prognosis of slow, progressive worsening of symptoms of these diseases is all that conventional medicine can offer people with these conditions.
The term “Idiopathic” is attached to nearly every one of these diseases. Idiopathic means the cause of the disease is unknown. Multiple Sclerosis (MS) is idiopathic in its origins. Parkinson’s disease is idiopathic in its origins. Amyotrophic Lateral Sclerosis (ALS) is idiopathic. Migraines are idiopathic. Muscular Dystrophies are idiopathic. Chronic Fatigue, Fibromyalgia, Insomnia, and so many more conditions are essentially termed idiopathic.
The conventional medical success rate, meaning the actual dramatic or long-term improvement for the treatment of MS, ALS, MD, and Parkinson’s disease is zero percent.
These neurologically compromised patients are very familiar with the term “remission”, which simply indicates a period of time that the drugs are effectively suppressing the symptoms. The actual cause of the illness is never being addressed by the drug therapy, therefore the remission is understood to be a temporary time period and the symptoms eventually return.
Once a person with one of these diseases loses normal function it is typically gone forever.
People with these neurological illnesses are told by their doctors to “Get used to the idea that life will never be the same again, and that you will experience a gradual or rapid decline. The best that conventional medicine can hope to do for you is to slow down the progression of your disease. There is no known cause and no known cure.”
The patient data of one new Translational/Clinical research center now available to patients in the U.S. for diagnostics and treatment, indicates the success rate of symptom remediation from CCSVH intervention can be categorized with an estimated 40% of compromised patients experiencing dramatic correction of their symptoms, another 35% experiencing good relief of their symptoms, while another 20% experience no relief in the short term after intervention, and approximately 5% experience a slight worsening of their symptoms.
The tendency of many “uninformed medical nay sayers” is to focus on the estimated 5% who possibly worsened in the short term after intervention. However, it is reported that some seem to have substantial improvements after 6 months to a year, post intervention.
One must remember that 100% of people using drug therapy for these same conditions are experiencing inevitable worsening. By their doctor’s admission they are never expected to improve, doomed only to manage and hopefully slow the worsening, until death.
It is the hope of real and significant improvement by a different treatment approach that has led many people to seek out CCSVH intervention.
Many of these people when asked, state that they feel the potential benefits far outweigh the risks, and at worst they will always have the conventional drugs to fall back on.
Some successes of CCSVH are quite dramatic with reports of
a) Complete recovery after many years of paralysis and neuropathies
b) Restoration of physical and mental energy.
c) Clearness of thought and improved memory.
d) Complete disappearance of pains in every part of the body.
e) Improved vision and diminution of tinnitus (ringing in the ears).
“There is one case I witnessed recently of an MS patient who was legally blind in one eye, whose eyesight was restored to near normal vision during the intervention procedure.”
Even if these cases were the exception rather than the rule, there are no exceptional results ever reported such as these in the conventional drug therapy approach for such neurodegenerative conditions.
The number of success stories with CCSVH intervention worldwide is often so dramatic, such as reversal of muscular paralysis, that some notable neurologists, physiologists, and clinicians are now questioning the validity of the long-held belief that demyelination conditions are the true cause of paralysis.
These physicians are having to rethink whether hyper intense, white matter lesions on the brain in MS cases are the cause of any symptom, or are they just the result of the hypertension of CCSVH causing a Leaky Brain Syndrome within the blood brain barrier (BBB) of the cerebral veins, resulting in white matter inflammation from the diapedesis (migration of red and white blood cells through the BBB) and other BBB permeability dysfunction of this specialized cerebral endothelial tissue.
Essentially these unwanted cells and metabolic debris in the brain’s white matter tissue could be classified simply as unnatural “waste” in this cortex brain tissue.
A poignant reality is there is enough direct and clear evidence of significant patient improvements that it should be deemed “doctor irresponsibly” not to order vascular diagnostic MRI/MRA image screening for patients with any suspect neurodegenerative or neuromuscular diagnosis.
The arteries bring nutritive blood to the brain and the veins drain the spent blood down and out of the brain. When a vein becomes narrow or physiologically constricted, the result can be retrograde (reverse) flow to the brain, away from the heart, creating increased intracranial pressure within the brain’s cerebral vessels.
This venous cerebral hypertension leads to a myriad of symptoms, as the body’s main control computer, the brain, malfunctions from increased and abnormal intravascular pressure, altered fluid dynamics, and iron toxicity as a form of iron called hemosiderin from the hypertensive venous blood.
This iron escapes from the red blood cells that have migrated through cerebral endothelial tissues into the brain tissue surrounding the affected veins.
The downstream effect on the body is noted to be direct symptomatic neurological disturbances.
In addition, there may be direct autonomic dysregulation, resulting in altered visceral (organs and glands) functional disturbances and altered metabolism, with measurable desaturation of the brain tissues gases ultimately affecting every aspect of the human organism.
As stated by one notable U.S. vascular interventionalists, the surgical intervention by balloon angioplasty for CCSVH is analogous to a “plumber snaking the drains in a house”.
While the stopped up sink or toilet has little to do with the incoming water pipes (arteries), the draining (veins) of the incoming water is very important or there will be a definite mess.
When a conventional medical doctor finds that their patient has clogged arteries the patient is immediately scheduled for angioplasty and possibly a stent placement.
There should be no hesitation to do the same when the blood flow in the vein is severely impeded.
This is the very essence of the venous condition CCSVI / CCSVH.
Dr. David A. Jernigan is the founder of Hansa Center for Optimum Health in Wichita, Kansas. http://www.hansacenter.com 316-686-5900 Dr. Jernigan is also the President of the American Biological Medicine Association.
